Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial) (Q36374231)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial) |
scientific article |
Statements
1 reference
Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial) (English)
1 reference
Akira Hata
1 reference
Reiko Aoyagi
1 reference
Hiromichi Hamada
1 reference
Yasunori Sato
1 reference
Hiroyuki Suzuki
1 reference
Yoshihiro Onouchi
1 reference
Ryota Ebata
1 reference
Kengo Nagashima
1 reference
Moe Terauchi
1 reference
Masaru Terai
1 reference
Hideki Hanaoka
1 reference
KAICA Trial Investigators
1 reference
1 December 2015
1 reference
1 reference
e009562
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference